Name : Biotinylated Human HLA-A*24:02&B2M&GP100 Intron 4 (VYFFLPDHL) Monomer Protein
Product Source :
Recombinant Biotinylated Human HLA-A*24:02&B2M&GP100 Intron 4 (VYFFLPDHL) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. It contains Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M) and VYFFLPDHL peptide.[Accession | AAA59600.1(HLA-A*24:02)&P61769(B2M)&VYFFLPDHL]
Molecular Weight :
The protein has a predicted MW of 50.40 kDa. Due to glycosylation, the protein migrates to 55-63 kDa based on Tris-Bis PAGE result.
Endotoxin Level :
Less than 1EU per μg by the LAL method.
Purity :
> 95% as determined by Tris-Bis PAGE> 95% as determined by HPLC
Formulation :
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution :
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage and Stability :
-20 to -80°C for 12 months as supplied from date of receipt.-80°C for 3-6 months after reconstitution.2-8°C for 2-7 days after reconstitution.Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Product Concentration :
Tris-Bis PAGE Biotinylated Human HLA-A*24:02&B2M&GP100 Intron 4 (VYFFLPDHL) Monomer on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. SEC-HPLC The purity of Biotinylated Human HLA-A*24:02&B2M&GP100 Intron 4 (VYFFLPDHL) Monomer is greater than 95% as determined by SEC-HPLC.
Background :
Glycoprotein 100, gp100 or Melanocyte protein PMEL is 661 amino acids long and is a type I transmembrane glycoprotein enriched in melanosomes, which are the melanin-producing organelles in melanocytes. This protein is involved in melanosome maturation. The Human HLA-A*0201 gp100 (YLEPGPVTA) complex Protein is a complex of HLA-A*0201 of the MHC Class I, B2M and YLEPGPVTA peptide of the gp100.
Synonyms :
HLA-A*24:02; HLA-A2402; MHC I; gp100; Glycoprotein 100; ME20-M; P100; GP100 Intron 4; Intron 4
References & Citations :
(1)Abad J D , Wrzensinski C , Overwijk W , et al. T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma Model[J]. Journal of Immunotherapy, 2008, 31(1):1-6.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
UBE2F Protein
TGF beta 3/TGFB3 Protein
Popular categories:
Complement Component 8
Growth Differentiation Factor